Proteinea

Proteinea is an AI-driven biotechnology company engineering next-generation therapeutic antibodies. It integrates protein language models, computational biology and biological automation to design, optimize and validate biologics faster and more safely. Proteinea is the creator of Ankh, an optimized general-purpose protein language model, and operates a Protein Engineering Platform (PEP) for multi-parameter optimization and RaGene for AI-driven codon/gene optimization, with a focus on rational Fc-domain engineering for context-specific immune tuning, enhanced half-life and targeted biodistribution. Headquartered in Cairo, Egypt with offices in Cambridge/ Boston, MA and a presence at KAUST, Saudi Arabia. Backed by 500 Global, IndieBio/SOSV, Shorooq Partners, Sawari Ventures and others. The company exposes research software (open-source models and benchmarks) rather than a public developer API.

Proteinea is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Artificial Intelligence, Machine Learning, and Protein Engineering.

Proteinea’s developer surface includes support and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

12.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyArtificial IntelligenceMachine LearningProtein EngineeringDrug DiscoveryAntibodiesComputational BiologyOpen SourceLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 12.1/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.9 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/proteinea: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Build 2

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Packages

Packages

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: proteinea
name: Proteinea
description: Proteinea is an AI-driven biotechnology company engineering next-generation therapeutic antibodies. It integrates
  protein language models, computational biology and biological automation to design, optimize and validate biologics faster
  and more safely. Proteinea is the creator of Ankh, an optimized general-purpose protein language model, and operates a Protein
  Engineering Platform (PEP) for multi-parameter optimization and RaGene for AI-driven codon/gene optimization, with a focus
  on rational Fc-domain engineering for context-specific immune tuning, enhanced half-life and targeted biodistribution. Headquartered
  in Cairo, Egypt with offices in Cambridge/ Boston, MA and a presence at KAUST, Saudi Arabia. Backed by 500 Global, IndieBio/SOSV,
  Shorooq Partners, Sawari Ventures and others. The company exposes research software (open-source models and benchmarks)
  rather than a public developer API.
url: https://raw.githubusercontent.com/api-evangelist/proteinea/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://github.com/proteinea.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- 500-global
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Artificial Intelligence
- Machine Learning
- Protein Engineering
- Drug Discovery
- Antibodies
- Computational Biology
- Open Source
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/proteinea-domain-security.yml
- type: Website
  url: https://proteinea.com
- type: GitHubOrganization
  url: https://github.com/proteinea
- type: PrivacyPolicy
  url: https://www.proteinea.com/privacy-policy
- type: Support
  url: https://www.proteinea.com/contact-us
- type: Packages
  url: packages/proteinea-packages.yml
x-enrichment:
  date: '2026-07-20'
  status: enriched
  artifacts_added: 2
  pass: local-v1